hy·per·ka·le·mi·a

(hī′pər-kā-lē′mē-ə)

An abnormally high concentration of potassium ions in the blood.

[hyper- + New Latin kalium, potassium; see hypokalemia + -emia.]

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

hy•per•ka•le•mi•a

(ˌhaɪ pər kəˈli mi ə)

n.

an abnormally high concentration of potassium in the blood.

[1945–50; hyper- + New Latin kal(ium) potassium (see alkali, -ium²) + -emia]

hy`per•ka•le′mic, adj.

ThesaurusAntonymsRelated WordsSynonymsLegend:

Noun

hyperkalemia - higher than normal levels of potassium in the circulating blood; associated with kidney failure or sometimes with the use of diuretic drugs

symptom - (medicine) any sensation or change in bodily function that is experienced by a patient and is associated with a particular disease

hypokalemia - abnormally low level of potassium in the circulating blood leading to weakness and heart abnormalities; associated with adrenal tumors or starvation or taking diuretics

Translations

hyperkalémie

hy·per·ka·le·mi·a

n. hipercalemia, hiperpotasemia, aumento excesivo de potasio en la sangre.

English-Spanish Medical Dictionary © Farlex 2012

Mentioned in

References in periodicals archive

Summary: Hyperkalaemia is a disease in which the levels of potassium are higher than normal.

Hyperkalaemia Treatment Market Status, Segment by Region, Type and Future Forecast Until 2028

However, they carry a risk of hyperkalaemia, especially for people with renal impairment or those taking drugs that also increase potassium concentration, eg ACE-inhibitors, ARBs and beta-blockers.

Understanding diuretics

UK-based AstraZeneca's Lokelma (sodium zirconium cyclosilicate) has achieved statistically significant and clinically meaningful improvement in treating hyperkalaemia in patients with end-stage renal disease on haemodialysis in the phase 111b Dialize trial, it was reported on Monday.

AstraZeneca's Lokelma achieves improvement in phase 111b Dialize trial

AstraZeneca presented results from the Phase IIIb DIALIZE trial which investigated the efficacy and safety of Lokelma for the treatment of hyperkalaemia in patients with end-stage renal disease on haemodialysis.

AstraZeneca says Lokelma demonstrated efficacy in Phase IIIb DIALIZE trial

Hyperkalaemia is a potentially life-threatening condition frequently encountered in hospitalised patients.

Life-threatening hyperkalaemia due to trimethoprim in a patient treated for Pneumocystis jirovecii pneumonia

On the 16th day of the follow-up, pyuria, hiponatraemia, hyperkalaemia, and metabolic acidosis were detected during hospitalization.

A potential serious complication in infants with congenital obstructive uropathy: Secondary pseudohypoaldosteronism

[USPRwire, Thu Jan 03 2019] The growing prevalence of chronic kidney disease and cardiac arrhythmias is expected to be among major factors driving the growth of the Hyperkalaemia Treatment Market over the forecast period.

Global Hyperkalaemia Treatment Market Scenario Highlighting Major Drivers & Trends, 2018-2028

Lancet ([IF.sub.2016] = 47.831) with only one article, entitled "Hyperkalaemia in a Thai man" (Smit, 1999), had the highest [IF.sub.2016].

Publicaciones de Brunei en el Science Citation Index Expanded (1973-2016): Bibliometria y comparacion con otros paises tropicales

Firstly, concerns that high consumption of fruit and vegetable leads to increased consumption of potassium and subsequent risk of hyperkalaemia. The authors agree that the issue warrants further study, but suggest the recommendation of fruit and vegetables with low potassium content in addition to close potassium monitoring.

Arguments for and against the Mediterranean diet in patients with chronic kidney disease